FTRE
Fortrea Holdings Inc.
NASDAQ: FTRE · HEALTHCARE · BIOTECHNOLOGY
$11.50
+8.90% today
Updated 2026-04-30
Market cap
$998.82M
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-10.81
Dividend yield
—
52W range
$4 – $19
Volume
1.5M
Fortrea Holdings Inc. (FTRE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $200.90M | $169.80M | $82.70M | $168.40M | $262.80M | $113.50M |
| Capital expenditures | $24.00M | $26.50M | $54.40M | $40.30M | $25.50M | $25.20M |
| Depreciation | $119.00M | $166.30M | $93.60M | $98.00M | $98.00M | — |
| Stock-based comp | $23.10M | $27.50M | $25.40M | $42.70M | $58.40M | $74.40M |
| Free cash flow | $176.90M | $143.30M | $28.30M | $128.10M | $237.30M | $88.30M |
| Investing cash flow | $-161.20M | $-26.20M | $-54.00M | $-31.80M | $251.60M | — |
| Financing cash flow | $-33.10M | $-128.50M | $-6.30M | $-140.80M | $-497.80M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |